By contrast, intracellular S100A9 is not co-localized with hypo-phosphorylated tau as it was examined by sequential immunostaining of the same tissues (supplemental file 4), indicating that S100A9 may not be associated with tau-pathology, which is another key feature of AD. This evidence concerns the gene S100A9 and Alzheimer disease.